NZ193077A - Peptides with ubiquitin-like activity; and pharmaceutical compositions - Google Patents

Peptides with ubiquitin-like activity; and pharmaceutical compositions

Info

Publication number
NZ193077A
NZ193077A NZ193077A NZ19307780A NZ193077A NZ 193077 A NZ193077 A NZ 193077A NZ 193077 A NZ193077 A NZ 193077A NZ 19307780 A NZ19307780 A NZ 19307780A NZ 193077 A NZ193077 A NZ 193077A
Authority
NZ
New Zealand
Prior art keywords
peptide
lys
sar
gln
peptides
Prior art date
Application number
NZ193077A
Other languages
English (en)
Inventor
G Goldstein
G Heavner
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NZ193077A publication Critical patent/NZ193077A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ193077A 1979-03-14 1980-03-07 Peptides with ubiquitin-like activity; and pharmaceutical compositions NZ193077A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/020,157 US4215111A (en) 1979-03-14 1979-03-14 Peptides having ubiquitin-like activity

Publications (1)

Publication Number Publication Date
NZ193077A true NZ193077A (en) 1984-05-31

Family

ID=21797065

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ193077A NZ193077A (en) 1979-03-14 1980-03-07 Peptides with ubiquitin-like activity; and pharmaceutical compositions

Country Status (18)

Country Link
US (1) US4215111A (Direct)
EP (1) EP0016612B1 (Direct)
JP (1) JPS55143946A (Direct)
AT (1) ATE1856T1 (Direct)
AU (1) AU544923B2 (Direct)
CA (1) CA1146166A (Direct)
DE (1) DE3061127D1 (Direct)
DK (1) DK149091C (Direct)
ES (1) ES489521A0 (Direct)
FI (1) FI67691C (Direct)
GR (1) GR68038B (Direct)
IE (1) IE49423B1 (Direct)
IL (1) IL59603A (Direct)
NO (1) NO149998C (Direct)
NZ (1) NZ193077A (Direct)
PT (1) PT70948B (Direct)
YU (1) YU41913B (Direct)
ZA (1) ZA801483B (Direct)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369137A (en) * 1980-06-17 1983-01-18 Ortho Pharmaceutical Corporation N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US4289759A (en) * 1980-06-23 1981-09-15 Ortho Pharmaceutical Corporation Immunoregulatory diketopiperazine compounds
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
JPH01104193A (ja) * 1986-06-10 1989-04-21 Kyowa Hakko Kogyo Co Ltd 新規ポリペプチド
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5770720A (en) * 1995-08-30 1998-06-23 Barnes-Jewish Hospital Ubiquitin conjugating enzymes having transcriptional repressor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113858A (en) * 1975-01-20 1978-09-12 St. Luke's Hospital Novel compounds, compositions and methods of their use
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
SE446866B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
NZ189101A (en) * 1977-12-08 1984-07-06 Ortho Pharma Corp Polypeptides having the ability to induce differentiation of both th-1+ t-lymphocytes and bu-1+ b-lymphocytes;pharmaceutical compositions

Also Published As

Publication number Publication date
JPH0153268B2 (Direct) 1989-11-13
NO149998C (no) 1984-08-01
ES8103026A1 (es) 1981-02-16
YU65980A (en) 1984-02-29
CA1146166A (en) 1983-05-10
PT70948B (en) 1981-06-24
DE3061127D1 (en) 1982-12-30
GR68038B (Direct) 1981-10-27
IL59603A (en) 1983-02-23
EP0016612A2 (en) 1980-10-01
AU5631380A (en) 1980-09-18
EP0016612A3 (en) 1981-01-07
FI800779A7 (fi) 1980-09-15
IL59603A0 (en) 1980-06-30
NO149998B (no) 1984-04-24
DK149091C (da) 1986-06-16
DK149091B (da) 1986-01-20
US4215111A (en) 1980-07-29
PT70948A (en) 1980-04-01
NO800724L (no) 1980-09-15
ATE1856T1 (de) 1982-12-15
FI67691C (fi) 1985-05-10
EP0016612B1 (en) 1982-11-24
IE800515L (en) 1980-09-14
AU544923B2 (en) 1985-06-20
ZA801483B (en) 1981-10-28
DK109180A (da) 1980-09-15
IE49423B1 (en) 1985-10-02
ES489521A0 (es) 1981-02-16
FI67691B (fi) 1985-01-31
YU41913B (en) 1988-02-29
JPS55143946A (en) 1980-11-10

Similar Documents

Publication Publication Date Title
US4190646A (en) Polypeptide compositions and methods
US4261886A (en) Peptides having thymopoietin-like activity
US4629723A (en) Potent thymopentin analogs
EP0602004A1 (en) Peptides having T cell helper activity
US4215112A (en) Tripeptides and methods
US4612365A (en) Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4002740A (en) Tridecapeptide compositions and methods
EP0016612B1 (en) Peptides having ubiquitin-like activity, process for their preparation, therapeutic compositions containing them and their use
US4190647A (en) Polypeptides and methods
EP0018182B1 (en) Peptides having thymopoietin-like activity, therapeutic compositions containing them, and process for their preparation
US4397842A (en) Peptides having thymopoietin-like activity
US3856770A (en) Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
CA1105925A (en) Pentapeptide compositions and methods
IE47611B1 (en) Polypeptides comprising a tetrapeptide segment,pharmaceutical compositions thereof,and processes for the preparation thereof
US4866121A (en) B cell differentiating peptides and conjugates thereof
CA1105923A (en) Pentapeptides and methods
US4258151A (en) Pentapeptide modified resin
US4258152A (en) Pentapeptide modified resin
GB1565032A (en) Polypeptide compositions and methods for their manufacture
US4232008A (en) Tetrapeptides and methods
JPH0135839B2 (Direct)
GB1585736A (en) Polypeptides and methods for their production